MetLife Investment Management (MIM) has announced the successful closing of approximately $1.2 billion in commitments to its MetLife Investment Private Equity Partners Fund III (MIPEP III). This milestone expands MIM's specialized private equity platform designed for institutional investors. The transaction utilizes a managed secondary sale structure, signaling continued growth in MIM's ability to execute large-scale, complex private market solutions for its global client base.
MIPEP III Managed Secondary Transaction Details
The MIPEP III fund closed with approximately $1.2 billion in commitments, focusing on a managed secondary sale transaction. Through this structure, the new fund acquired a diverse portfolio consisting of nearly 80 private equity, venture capital, and equity co-investment interests. These acquired assets represent approximately $754 million in value, with total funded and unfunded commitments reaching $966 million from MetLife affiliates. The transaction was anchored by funds managed by Lexington Partners, which acted as the lead investor. This strategic move follows the successful closings of MIPEP I in 2022, which raised $1.6 billion, and MIPEP II in 2024, which raised $1.2 billion. The transaction involved financial advisory from Evercore and legal counsel from Sidley Austin LLP.
MetLife Private Equity Platform Evolution
MIM's private equity platform continues to demonstrate significant scale and deployment capabilities within the alternative investment landscape. The firm's private equity team has deployed nearly $20.9 billion in alternative investments over the last decade. This recent fund closing is supported by the strong performance of the MetLife general account's private equity portfolio, which held $14.2 billion in private equity assets as of March 31, 2026. By utilizing managed secondary transactions, MIM is positioning its platform to meet the evolving demand from institutional investors for innovative structures that provide access to diversified, high-quality, and globalized private market portfolios.
Key Takeaways
- MIPEP III closed with approximately $1.2 billion in total commitments.
- The fund acquired nearly 80 private equity, venture capital, and equity co-investment interests.
- MetLife's private equity team has deployed nearly $20.9 billion in alternative investments over the last ten years.
FinanceInsyte's Take
In our view, the successful closing of MIPEP III reinforces MetLife Investment Management's dominance in the managed secondary market. By repeatedly executing large-scale transactions—moving from $1.6 billion in 2022 to $1.2 billion today—MIM is proving that its structured approach to secondary sales is a repeatable and scalable model. This signals to institutional investors that MIM can effectively bridge the gap between traditional asset management and specialized private equity access, leveraging its massive $14.2 billion general account to drive platform liquidity and institutional-grade diversification.
Questions & Answers
How does the MIPEP III structure benefit institutional investors?
The fund utilizes a managed secondary sale transaction, allowing investors to access a diversified portfolio of nearly 80 global private equity, venture capital, and co-investment interests through a single, structured vehicle.
What is the scale of MetLife's private equity involvement?
MIM's private equity team has deployed nearly $20.9 billion in alternative investments over the past decade, supported by a general account holding $14.2 billion in private equity assets as of March 31, 2026.
Who were the primary partners in the MIPEP III transaction?
Lexington Partners served as the lead investor anchoring the managed secondary sale, while Evercore acted as the financial advisor and placement agent, with Sidley Austin LLP providing legal counsel.
Source: BUSINESSWIRE
